
The appreciation in the value of the INR vis-à-vis the USD has caused Pharma & InfoTech stocks to under-perform the Index. Daljeet Kohli explains the extent of the impact and offers valuable advice on what investors should do
Daljeet Kohli of IndiaNivesh has mastered the art of homing in on stocks just before they perk up. Apart from Alembic and J. B. Chemical, Cadila is another example of this splendid stock selection
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Rakesh Jhunjhunwala
Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala
Recent Comments